An exploration of the implementation of FeNO testing and a FeNO-guided algorithm in primary care in England
An exploration of the implementation of FeNO testing and a FeNO-guided algorithm in primary care in England
Abstract
Introduction: Fractional exhaled nitric oxide (FeNO) testing has been implemented in some areas of England, predominantly for asthma diagnosis. This study is nested in an ongoing randomised controlled trial investigating use of FeNO testing and a FeNO-guided algorithm, in primary care asthma reviews for ages 12 and over.
Aims: Identify perceived barriers, facilitators, and contextual influences on implementing FeNO testing and a FeNO-guided algorithm in primary care asthma reviews.
Methods: In-depth interviews were conducted with key stakeholders in relevant roles, including general practitioners, nurses, pharmacists, respiratory physiologists, patient representatives, and advocates. Snowball and theoretical sampling were used to maximise transferability. Data were thematically analysed.
Findings: Findings suggest positive perceptions of FeNO and the FeNO-guided algorithm, particularly when algorithmic recommendations align with national guidance. Pre-selecting specific patient groups for the intervention and training assistants to conduct FeNO testing may reduce concerns about requiring additional funding and clinical time to implement the intervention. Clinicians perceive less experienced practitioners may have difficulty placing algorithm recommendations in the context of clinical assessments. Broader asthma training and support is needed to ensure optimal patient care and shared decision-making. Ensuring system interoperability with electronic medical records may aid implementation.
Conclusions: Strategies to select patients most likely to benefit, harness funding, enhance system interoperability and ensure appropriate training, could maximise sustained implementation.
primary health care, nitric oxide, fractional exhaled nitric oxide (FeNO), asthma
Lewis, Grace
190ea02e-acb2-4cff-a99d-18df28bb1a2e
Morton, Kate
9981c3b0-8602-48ea-b9de-58592f5483a1
Santillo, Marta
67fe3fd0-9518-45fa-9e06-68d5e56cb811
Yardley, Lucy
64be42c4-511d-484d-abaa-f8813452a22e
Wang, Kay
35ab64db-e4d5-4b4b-9225-54c9bcc6d143
Ainsworth, Ben
b02d78c3-aa8b-462d-a534-31f1bf164f81
Tonkin-Crine, Sarah
453132bf-d8a2-41c5-999d-cb2fcfb45239
30 October 2024
Lewis, Grace
190ea02e-acb2-4cff-a99d-18df28bb1a2e
Morton, Kate
9981c3b0-8602-48ea-b9de-58592f5483a1
Santillo, Marta
67fe3fd0-9518-45fa-9e06-68d5e56cb811
Yardley, Lucy
64be42c4-511d-484d-abaa-f8813452a22e
Wang, Kay
35ab64db-e4d5-4b4b-9225-54c9bcc6d143
Ainsworth, Ben
b02d78c3-aa8b-462d-a534-31f1bf164f81
Tonkin-Crine, Sarah
453132bf-d8a2-41c5-999d-cb2fcfb45239
Lewis, Grace, Morton, Kate, Santillo, Marta, Yardley, Lucy, Wang, Kay, Ainsworth, Ben and Tonkin-Crine, Sarah
(2024)
An exploration of the implementation of FeNO testing and a FeNO-guided algorithm in primary care in England.
European Respiratory Congress 2024, Vienna, Austria, Vienna, Austria.
07 - 11 Sep 2024.
(doi:10.1183/13993003.congress-2024.PA739).
Record type:
Conference or Workshop Item
(Poster)
Abstract
Abstract
Introduction: Fractional exhaled nitric oxide (FeNO) testing has been implemented in some areas of England, predominantly for asthma diagnosis. This study is nested in an ongoing randomised controlled trial investigating use of FeNO testing and a FeNO-guided algorithm, in primary care asthma reviews for ages 12 and over.
Aims: Identify perceived barriers, facilitators, and contextual influences on implementing FeNO testing and a FeNO-guided algorithm in primary care asthma reviews.
Methods: In-depth interviews were conducted with key stakeholders in relevant roles, including general practitioners, nurses, pharmacists, respiratory physiologists, patient representatives, and advocates. Snowball and theoretical sampling were used to maximise transferability. Data were thematically analysed.
Findings: Findings suggest positive perceptions of FeNO and the FeNO-guided algorithm, particularly when algorithmic recommendations align with national guidance. Pre-selecting specific patient groups for the intervention and training assistants to conduct FeNO testing may reduce concerns about requiring additional funding and clinical time to implement the intervention. Clinicians perceive less experienced practitioners may have difficulty placing algorithm recommendations in the context of clinical assessments. Broader asthma training and support is needed to ensure optimal patient care and shared decision-making. Ensuring system interoperability with electronic medical records may aid implementation.
Conclusions: Strategies to select patients most likely to benefit, harness funding, enhance system interoperability and ensure appropriate training, could maximise sustained implementation.
This record has no associated files available for download.
More information
Published date: 30 October 2024
Venue - Dates:
European Respiratory Congress 2024, Vienna, Austria, Vienna, Austria, 2024-09-07 - 2024-09-11
Keywords:
primary health care, nitric oxide, fractional exhaled nitric oxide (FeNO), asthma
Identifiers
Local EPrints ID: 496657
URI: http://eprints.soton.ac.uk/id/eprint/496657
PURE UUID: 5842e690-472f-4b30-9e9d-986cd90de793
Catalogue record
Date deposited: 07 Jan 2025 18:53
Last modified: 10 Jan 2025 02:47
Export record
Altmetrics
Contributors
Author:
Grace Lewis
Author:
Kate Morton
Author:
Marta Santillo
Author:
Kay Wang
Author:
Ben Ainsworth
Author:
Sarah Tonkin-Crine
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics